Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer
QMRO Home
Barts Cancer Institute
Centre for Experimental Cancer Medicine
HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer
QMRO Home
Barts Cancer Institute
Centre for Experimental Cancer Medicine
HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer
Volume
22
Pagination
1371 - 1377
DOI
10.1158/1078-0432.CCR-15-2044
Journal
CLINICAL CANCER RESEARCH
Issue
6
ISSN
1078-0432
Metadata
Show full item record
Authors
Xu, C-F; Johnson, T; Wang, X; Carpenter, C; Graves, AP; Warren, L; Xue, Z; King, KS; Fraser, DJ; Stinnett, S
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11018
Collections
Centre for Experimental Cancer Medicine
[130]
Licence information
• “The final publication is available at http://clincancerres.aacrjournals.org/content/early/2016/01/08/1078-0432.CCR-15-2044.abstract”